Halozyme Therapeutics shares owned by Lawrence Kelly & Associates, Incorporated
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lawrence Kelly & Associates, Incorporated
from 13F filings
Historical chart of Lawrence Kelly & Associates, Incorporated investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lawrence Kelly & Associates, Incorporated consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lawrence Kelly & Associates, Incorporated
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $117k | 1.5k | 78.27 |
More positions owned by Lawrence Kelly & Associates, Incorporated
View all positions for Lawrence Kelly & Associates, Incorporated